199 related articles for article (PubMed ID: 23955540)
1. Cancer stemness in Wnt-driven mammary tumorigenesis.
Monteiro J; Gaspar C; Richer W; Franken PF; Sacchetti A; Joosten R; Idali A; Brandao J; Decraene C; Fodde R
Carcinogenesis; 2014 Jan; 35(1):2-13. PubMed ID: 23955540
[TBL] [Abstract][Full Text] [Related]
2. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
3. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
[TBL] [Abstract][Full Text] [Related]
4. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.
Shin DH; Park JH; Lee JY; Won HY; Jang KS; Min KW; Jang SH; Woo JK; Oh SH; Kong G
Oncotarget; 2015 Jul; 6(19):17276-90. PubMed ID: 25938540
[TBL] [Abstract][Full Text] [Related]
6. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
7. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
Ling H; Sylvestre JR; Jolicoeur P
Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
[TBL] [Abstract][Full Text] [Related]
8. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
9. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
10. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
11. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
[TBL] [Abstract][Full Text] [Related]
13. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
[TBL] [Abstract][Full Text] [Related]
14. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
16. A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer.
Vassilopoulos A; Chisholm C; Lahusen T; Zheng H; Deng CX
Oncogene; 2014 Nov; 33(47):5477-82. PubMed ID: 24317509
[TBL] [Abstract][Full Text] [Related]
17. IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.
Rota LM; Albanito L; Shin ME; Goyeneche CL; Shushanov S; Gallagher EJ; LeRoith D; Lazzarino DA; Wood TL
Cancer Res; 2014 Oct; 74(19):5668-79. PubMed ID: 25092896
[TBL] [Abstract][Full Text] [Related]
18. Mammary tumor regression elicited by Wnt signaling inhibitor requires IGFBP5.
Liu BY; Soloviev I; Huang X; Chang P; Ernst JA; Polakis P; Sakanaka C
Cancer Res; 2012 Mar; 72(6):1568-78. PubMed ID: 22307840
[TBL] [Abstract][Full Text] [Related]
19. Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome.
Holland JD; Györffy B; Vogel R; Eckert K; Valenti G; Fang L; Lohneis P; Elezkurtaj S; Ziebold U; Birchmeier W
Cell Rep; 2013 Dec; 5(5):1214-27. PubMed ID: 24290754
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
